Cargando…

Chronic Urticaria Treatment with Omalizumab—Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy

Biomarkers that are able to predict the response to omalizumab (OMA) in chronic spontaneous urticaria (CSU) are highly valued. The aim of our study was to evaluate the UAS7 (urticaria activity score assessed for 7 days), DLQI (dermatology life quality index), SII (systemic immune-inflammation index)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarkowski, Bartłomiej, Ławniczak, Julia, Tomaszewska, Katarzyna, Kurowski, Marcin, Zalewska-Janowska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095242/ https://www.ncbi.nlm.nih.gov/pubmed/37048721 http://dx.doi.org/10.3390/jcm12072639

Ejemplares similares

The Predictive Role of Maternal Biological Markers and Inflammatory Scores NLR, PLR, MLR, SII, and SIRI for the Risk of Preterm Delivery
por: Hrubaru, Ingrid, et al.
Publicado: (2022)

Neuro–Immuno–Psychological Aspects of Chronic Urticaria
por: Tomaszewska, Katarzyna, et al.
Publicado: (2023)

Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review
por: Kosidło, Jakub Wiktor, et al.
Publicado: (2023)

NLR and PLR in Schizophrenia
por: Surati, Love, et al.
Publicado: (2022)

The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage
por: Wang, Rui-Hong, et al.
Publicado: (2023)

NLR, d-NLR and PLR can be affected by many factors
por: Bedel, Cihan, et al.
Publicado: (2021)

160 Selected psychological stress and cognitive function parameters in patients suffering from COVID-19 induced telogen effluvium
por: Tomaszewska, K., et al.
Publicado: (2022)

The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality
por: Citu, Cosmin, et al.
Publicado: (2022)

Predictive value of NLR and PLR in missed miscarriage
por: Liu, Dan, et al.
Publicado: (2022)

Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients
por: Ghobadi, Hassan, et al.
Publicado: (2022)

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
por: Yang, Ai-Ping, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) to predict postoperative pneumonia in elderly hip fracture patients
por: Yao, Wei, et al.
Publicado: (2023)

Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma
por: Xia, Wen-Kai, et al.
Publicado: (2016)

Predictive evaluation of SIRI, SII, PNI, and GPS in cholecystostomy application in patients with acute cholecystitis
por: Ethem Cakcak, İbrahim, et al.
Publicado: (2022)

The Significance of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Systemic Inflammatory Index (SII) in Predicting Severity and Adverse Outcomes in Acute Calculous Cholecystitis
por: Serban, Dragos, et al.
Publicado: (2023)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Incapacitating solar urticaria: successful treatment with omalizumab
por: Kieselova, Katarina, et al.
Publicado: (2019)

Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)
por: Modica, Roberta, et al.
Publicado: (2023)

Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer
por: Fang, Tianyi, et al.
Publicado: (2020)

Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism
por: Köse, Nuri, et al.
Publicado: (2020)

T cell activity in successful treatment of chronic urticaria with omalizumab
por: Sánchez-Machín, Inmaculada, et al.
Publicado: (2011)

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
por: Nam, Young-Hee, et al.
Publicado: (2012)

Dynamic Status of SII and SIRI Alters the Risk of Cardiovascular Diseases: Evidence from Kailuan Cohort Study
por: Li, Jun, et al.
Publicado: (2022)

ASSOCIATION OF LYMPHOCYTE COUNTS, NLR AND PLR WITH MORTALITY IN COVID-19 PATIENTS
por: Alagbe, AE, et al.
Publicado: (2021)

Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules
por: Offi, Chiara, et al.
Publicado: (2021)

Prognostic Role of NLR, PLR and MHR in Patients With Idiopathic Pulmonary Fibrosis
por: Chen, Yiran, et al.
Publicado: (2022)

Treatment of Severe Cold Contact Urticaria with Omalizumab: Case Reports
por: Brodská, Petra, et al.
Publicado: (2012)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Omalizumab for urticaria treatment in clinical practice: a case series
por: Lesiak, Aleksandra, et al.
Publicado: (2018)

Long term treatment with omalizumab in adolescent with refractory solar urticaria
por: Iannelli, Mauro, et al.
Publicado: (2021)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
por: Dekkers, Coco, et al.
Publicado: (2021)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
por: Kara, Rabia Oztas, et al.
Publicado: (2022)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022)

Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023)

Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment
por: Can Bostan, Ozge, et al.
Publicado: (2023)

Relationship between SIRI, SII values, and Alvarado score with complications of acute appendicitis during the COVID-19 pandemic
por: Cakcak, İbrahim Ethem, et al.
Publicado: (2022)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqgg61grdhurvk0aq6ujml31r3